IBDEI185 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20464,2)
 ;;=^340504
 ;;^UTILITY(U,$J,358.3,20465,0)
 ;;=D50.9^^97^961^26
 ;;^UTILITY(U,$J,358.3,20465,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20465,1,3,0)
 ;;=3^Iron Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,20465,1,4,0)
 ;;=4^D50.9
 ;;^UTILITY(U,$J,358.3,20465,2)
 ;;=^5002283
 ;;^UTILITY(U,$J,358.3,20466,0)
 ;;=D64.81^^97^961^2
 ;;^UTILITY(U,$J,358.3,20466,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20466,1,3,0)
 ;;=3^Anemia d/t Antineoplastic Chemotherapy
 ;;^UTILITY(U,$J,358.3,20466,1,4,0)
 ;;=4^D64.81
 ;;^UTILITY(U,$J,358.3,20466,2)
 ;;=^5002349
 ;;^UTILITY(U,$J,358.3,20467,0)
 ;;=D63.1^^97^961^4
 ;;^UTILITY(U,$J,358.3,20467,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20467,1,3,0)
 ;;=3^Anemia in Chronic Kidney Disease
 ;;^UTILITY(U,$J,358.3,20467,1,4,0)
 ;;=4^D63.1
 ;;^UTILITY(U,$J,358.3,20467,2)
 ;;=^332908
 ;;^UTILITY(U,$J,358.3,20468,0)
 ;;=D62.^^97^961^1
 ;;^UTILITY(U,$J,358.3,20468,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20468,1,3,0)
 ;;=3^Acute Blood Loss Anemia
 ;;^UTILITY(U,$J,358.3,20468,1,4,0)
 ;;=4^D62.
 ;;^UTILITY(U,$J,358.3,20468,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,20469,0)
 ;;=D51.9^^97^961^32
 ;;^UTILITY(U,$J,358.3,20469,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20469,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,20469,1,4,0)
 ;;=4^D51.9
 ;;^UTILITY(U,$J,358.3,20469,2)
 ;;=^5002289
 ;;^UTILITY(U,$J,358.3,20470,0)
 ;;=D51.3^^97^961^31
 ;;^UTILITY(U,$J,358.3,20470,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20470,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Dietary
 ;;^UTILITY(U,$J,358.3,20470,1,4,0)
 ;;=4^D51.3
 ;;^UTILITY(U,$J,358.3,20470,2)
 ;;=^5002287
 ;;^UTILITY(U,$J,358.3,20471,0)
 ;;=D51.0^^97^961^28
 ;;^UTILITY(U,$J,358.3,20471,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20471,1,3,0)
 ;;=3^Pernicious Anemia
 ;;^UTILITY(U,$J,358.3,20471,1,4,0)
 ;;=4^D51.0
 ;;^UTILITY(U,$J,358.3,20471,2)
 ;;=^5002284
 ;;^UTILITY(U,$J,358.3,20472,0)
 ;;=D50.0^^97^961^3
 ;;^UTILITY(U,$J,358.3,20472,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20472,1,3,0)
 ;;=3^Anemia d/t Blood Loss (Chronic)
 ;;^UTILITY(U,$J,358.3,20472,1,4,0)
 ;;=4^D50.0
 ;;^UTILITY(U,$J,358.3,20472,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,20473,0)
 ;;=E11.21^^97^961^18
 ;;^UTILITY(U,$J,358.3,20473,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20473,1,3,0)
 ;;=3^DM Type 2 w/ Nephropathy
 ;;^UTILITY(U,$J,358.3,20473,1,4,0)
 ;;=4^E11.21
 ;;^UTILITY(U,$J,358.3,20473,2)
 ;;=^5002629
 ;;^UTILITY(U,$J,358.3,20474,0)
 ;;=E11.22^^97^961^8
 ;;^UTILITY(U,$J,358.3,20474,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20474,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic CKD
 ;;^UTILITY(U,$J,358.3,20474,1,4,0)
 ;;=4^E11.22
 ;;^UTILITY(U,$J,358.3,20474,2)
 ;;=^5002630
 ;;^UTILITY(U,$J,358.3,20475,0)
 ;;=E11.29^^97^961^19
 ;;^UTILITY(U,$J,358.3,20475,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20475,1,3,0)
 ;;=3^DM Type 2 w/ Other Diabetic Kidney Complication
 ;;^UTILITY(U,$J,358.3,20475,1,4,0)
 ;;=4^E11.29
 ;;^UTILITY(U,$J,358.3,20475,2)
 ;;=^5002631
 ;;^UTILITY(U,$J,358.3,20476,0)
 ;;=E11.311^^97^961^20
 ;;^UTILITY(U,$J,358.3,20476,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20476,1,3,0)
 ;;=3^DM Type 2 w/ Unspec Diabetic Retinopathy w/ Macular edema
 ;;^UTILITY(U,$J,358.3,20476,1,4,0)
 ;;=4^E11.311
 ;;^UTILITY(U,$J,358.3,20476,2)
 ;;=^5002632
 ;;^UTILITY(U,$J,358.3,20477,0)
 ;;=E11.319^^97^961^21
 ;;^UTILITY(U,$J,358.3,20477,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20477,1,3,0)
 ;;=3^DM Type 2 w/ Unspec Diabetic Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,20477,1,4,0)
 ;;=4^E11.319
